Literature DB >> 2649316

Aeromonas as a human pathogen.

M Altwegg1, H K Geiss.   

Abstract

Although the first Aeromonas strain was described by Zimmermann as early as in 1890, it took 60 years until Caselitz established human pathogenicity of strains then called "Vibrio jamaicensis". Since then, and especially in the last 10 years, there have been increasing numbers of reports on different infections caused by members of the genus Aeromonas. These include sepsis; meningitis; cellulitis; necrotizing fasciitis; ecthyma gangrenosum; pneumonia; peritonitis; conjunctivitis; corneal ulcer; endophthalmitis; osteomyelitis; suppurative arthritis; myositis; subphrenic abscess; liver abscess; cholecystitis and/or ascending cholangitis; urinary tract infection; endocarditis; ear, nose, and throat infections; balanitis; etc. The role of Aeromonas in gastrointestinal disease is very controversial. Increasing epidemiological data suggest that these organisms play a major role in enteric infections, but so far enteropathogenicity has not been demonstrable in experiments where volunteers were given high numbers of Aeromonas possessing different virulence factors. Virulence factors include hemolysin(s), enterotoxin(s), hemagglutinins, invasivity, and others; but these are not found more frequently in strains isolated from patients with diarrhea than from healthy controls. Whether there is a correlation between species and disease remains to be elucidated and requires more information about the taxonomy of this genus.

Entities:  

Mesh:

Year:  1989        PMID: 2649316     DOI: 10.3109/10408418909105478

Source DB:  PubMed          Journal:  Crit Rev Microbiol        ISSN: 1040-841X            Impact factor:   7.624


  58 in total

1.  Identification of motile Aeromonas strains with the MicroScan WalkAway system in conjunction with the combo negative type 1S panels.

Authors:  J Vivas; A I Sáa; A Tinajas; L Barbeyto; L A Rodríguez
Journal:  Appl Environ Microbiol       Date:  2000-04       Impact factor: 4.792

2.  Aeromonas hydrophila blepharoconjunctivitis.

Authors:  J M Sire; P Ropert; P Y Donnio
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1990-12       Impact factor: 3.267

3.  Purification and characterization of the N-terminal domain of ExeA: a novel ATPase involved in the type II secretion pathway of Aeromonas hydrophila.

Authors:  Ian C Schoenhofen; Gang Li; Timothy G Strozen; S Peter Howard
Journal:  J Bacteriol       Date:  2005-09       Impact factor: 3.490

Review 4.  Recent advances in the study of the taxonomy, pathogenicity, and infectious syndromes associated with the genus Aeromonas.

Authors:  J M Janda
Journal:  Clin Microbiol Rev       Date:  1991-10       Impact factor: 26.132

5.  Prospective nationwide study of Aeromonas infections in France.

Authors:  Brigitte Lamy; Angeli Kodjo; Frédéric Laurent
Journal:  J Clin Microbiol       Date:  2009-02-25       Impact factor: 5.948

6.  Case reports: fatal necrotizing fasciitis caused by Aeromonas sobria in two diabetic patients.

Authors:  Yao-Hung Tsai; Kuo-Chin Huang; Tsung-Jen Huang; Robert Wen-Wei Hsu
Journal:  Clin Orthop Relat Res       Date:  2008-09-18       Impact factor: 4.176

7.  Thermal Inactivation of Aeromonas hydrophila As Affected by Sodium Chloride and Ascorbic Acid.

Authors:  M L Stecchini; I Sarais; A Giomo
Journal:  Appl Environ Microbiol       Date:  1993-12       Impact factor: 4.792

8.  Aeromonads in acute diarrhoea and asymptomatic infections in Nigerian children.

Authors:  S J Utsalo; F O Eko; O E Antia-Obong; C U Nwaigwe
Journal:  Eur J Epidemiol       Date:  1995-04       Impact factor: 8.082

9.  Distribution of Aeromonas phenospecies and genospecies among strains isolated from water, foods or from human clinical samples.

Authors:  M L Hänninen; A Siitonen
Journal:  Epidemiol Infect       Date:  1995-08       Impact factor: 2.451

10.  Impact of the ring-billed gull (Larus delawarensis) on the microbiological quality of recreational water.

Authors:  P Brousseau; P Simard; E Dewailly; M Meisels; D Ramsay; J Joly
Journal:  Appl Environ Microbiol       Date:  1993-04       Impact factor: 4.792

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.